Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PM vs GSK✓SelectedUSD · GSKPM vs GSK performance historyLatest closeAs of-1.47%11/16
Stock and ETF performance explorer

PM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+165.1%
GSK return
+46.9%
Excess return
+118.2%
Maximum drawdown
-22.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-0.1%-1.4%-1.4%
7D+1.5%-1.3%+2.8%+1.8%
30D-4.5%+2.7%-7.2%-5.1%
3M+3.9%+2.7%+1.1%+3.0%
6M+5.1%+3.3%+1.8%+4.2%
YTD+25.4%+6.5%+18.9%+23.4%
1Y+30.6%+10.7%+19.9%+27.4%
3Y+142.9%+64.4%+78.5%+111.4%
5Y+165.1%+46.7%+118.4%+129.9%
All+165.1%+46.9%+118.2%+129.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling